Kart Ayşegül, Özdel Kadir, Türkçapar Mehmet Hakan
Bakırköy Mental Health and Neurological Diseases Education and Research Hospital, Department of Psychiatry, İstanbul, Turkey.
University of Health Science, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Department of Psychiatry, Ankara, Turkey.
Noro Psikiyatr Ars. 2021 Sep 20;58(Suppl 1):S61-S65. doi: 10.29399/npa.27418. eCollection 2021.
Schizophrenia is a heterogeneous disorder that affects behavioral, affective, and cognitive domains and consists of positive and negative psychotic symptoms. Antipsychotic therapy is the first-line treatment for schizophrenia. However, treatment adherence levels are low. Even if there is good treatment compliance, residual symptoms and treatment resistance can be seen. As a result, recent schizophrenia treatment guidelines suggest Cognitive Behavioral Therapy (CBT) as adjunctive to antipsychotic therapy. CBT is known effective, especially on positive symptoms. This paper aims to review CBT practices and their effectiveness in schizophrenia.
精神分裂症是一种异质性疾病，会影响行为、情感和认知领域，由阳性和阴性精神病性症状组成。抗精神病药物治疗是精神分裂症的一线治疗方法。然而，治疗依从性较低。即使治疗依从性良好，仍可能出现残留症状和治疗抵抗。因此，最近的精神分裂症治疗指南建议将认知行为疗法（CBT）作为抗精神病药物治疗的辅助手段。CBT被认为是有效的，尤其是对阳性症状。本文旨在综述CBT在精神分裂症中的实践及其有效性。
